Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07820319

The Use of Single-Beat TE-e' in Evaluation of Left Atrial Pressure in Critically Ill Patients: The TELAP-ICU Trial

This study evaluates a new single-beat echocardiographic technique (TE-e', the time difference between the onset of the mitral inflow E wave and the septal e' wave on tissue Doppler imaging) for estimating left atrial pressure (LAP) in critically ill patients, comparing it against the standard two-beat method. The goal is to determine whether the faster, single-beat method gives results as reliable as the conventional method, and whether it can help identify patients with elevated left atrial pressure without an invasive procedure.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Adult Intensive Care Unit, Queen Mary Hospital

Hong Kong

Location status: Recruiting

Location contact

Wincy Ng, MBBS

CONTACT

[email protected]

22551331

About this study

Left atrial pressure (LAP) is an important measure in the care of critically ill patients but usually requires an invasive catheter to assess directly. Echocardiography offers a non-invasive alternative. One promising marker, TE-e' (the time difference between the onset of the mitral inflow E wave and the septal e' wave on tissue Doppler imaging), was recently incorporated into the 2025 American Society of Echocardiography (ASE) diastolic function guidelines. The conventional method for calculating TE-e' requires measurements from two separate heartbeats, introducing potential error from beat-to-beat heart rate variability - a common issue in the critically ill patients. This study assesses a novel single-beat method, in which both waveforms are captured on the same Doppler display within one cardiac cycle, eliminating that source of variability. Patients undergoing clinically indicated transthoracic echocardiography (TTE) in the Adult Intensive Care Unit of Queen Mary Hospital, Hong Kong will have TE-e' measured by both methods, along with other echocardiographic parameters associated with LAP, to evaluate correlation between the two methods and their relationship with clinically assessed LAP.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patients ≥18 years admitted to the QMH Adult Intensive Care Unit (AICU)
  • Requiring a transthoracic echocardiogram (TTE) as part of routine clinical care
  • TE-e' obtainable by both the conventional and the novel method

Exclusion criteria

  • Patients <18 years of age
  • Patients in atrial fibrillation
  • Patients with a poor TTE acoustic window
  • Patients in whom TE-e' is technically difficult to obtain or interpret by either method

Treatment and study plan

Echocardiography

Diagnostic Test

Full echocardiogram performed on recruited patients.

Primary outcomes

  1. Correlation between novel (single-beat) and conventional (two-beat) TE-e' values

    Time frame: At the time of index TTE (single time point for each patient) during the course of ICU stay (from day 1 of ICU admission till ICU discharge, up to 1 month)

Secondary outcomes

  1. Correlation between novel and conventional methods in obtaining septal e' and s' velocities - At time of index TTE

    Time frame: At the time of index TTE (single time point for each patient) during the course of ICU stay (from day 1 of ICU admission till ICU discharge, up to 1 month)

  2. Correlation between clinical evaluation of LAP and TE-e' value

    Time frame: At the time of index TTE (single time point for each patient) during the course of ICU stay (from day 1 of ICU admission till ICU discharge, up to 1 month)

  3. Correlation between other echocardiographic parameters of LAP (E/A ratio, LAVi, TR Vmax, lung ultrasound 6-point protocol) and TE-e' value

    Time frame: At the time of index TTE (single time point for each patient) during the course of ICU stay (from day 1 of ICU admission till ICU discharge, up to 1 month)

Study contacts

Contact information is provided by the study sponsor or research team.

Wincy Ng, MBBS

CONTACT

[email protected]

22551331

Sponsors and collaborators

Lead sponsor

Queen Mary Hospital, Hong Kong

Other

Registry information

Acronym: TELAP-ICU

Important dates

Study start
2026
Primary completion
2026
Study completion
2027
First posted
Sep 15, 2026
Registry last updated
Sep 15, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.